Novel ruthenium antimicrobial compounds.

Through exploitation of new chemical space, two antimicrobial complexes have been developed.

High activities on priority pathogens, antimicrobial efficacy and low toxicity in-vivo and ex-vivo. Low emergence of resistance and a novel target.

  • Antimicrobial compounds
  • Alternative antimicrobials
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

  • Academia
  • Company
  • Institute
  • NGO
  • Government

  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:

        We would like a partner to advise and assist on the next stages of our pre-clinical development plan.

        Metallobio are a prospective spin out company from the University of Sheffield developing two novel antimicrobial compounds.

        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!